Breakthrough experimental therapy to treat colon cancer, chronic inflammatory bowel disease

24 julio 2015

A groundbreaking experimental therapy has been discovered that has the ability to suppress the development of ulcerative colitis (UC), a disease which causes inflammation in the digestive tract and colon cancer. The treatment utilizes a chemical inhibitor able to block an RNA molecule (microRNA-214) involved in the transmission of genetic information.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/WEnMob6_IBU» height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/WEnMob6_IBU/150723211155.htm

Volver